Women seeking medication abortions face increasing state restrictions as FDA weighs action

México Noticias Noticias

Women seeking medication abortions face increasing state restrictions as FDA weighs action
México Últimas Noticias,México Titulares
  • 📰 NBCNews
  • ⏱ Reading Time:
  • 51 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 24%
  • Publisher: 86%

Women seeking abortions through medication face increasing state restrictions as the FDA weighs action.

The agency's move, along with the explosive growth in telehealth services and increase in self-managed medication abortions, sparked a flurry of legislative activity in Ohio and other Republican-led states. They further limited access to the pills, adding to restrictions on their use already in place in dozens of states around the nation.

Oklahoma state Sen. Julie Daniels, who authored the medical abortion legislation, said at the time that the FDA's moves to relax requirements for the pills prompted her to act. In addition to banning the mailing of abortion pills, the legislation would require a health care provider to handle any medical complications from their use and direct the state to develop certification requirements to prescribe the drugs.

Liebel and other anti-abortion activists contend that mifepristone is not safe for women to take unsupervised at home and argue that it’s led to many rushing to emergency rooms. But of nearly 4 million women who have taken the drug since 2000,there were reports of 24 associated deaths as of 2018, including two cases of ectopic pregnancy and several cases of severe sepsis.

In Missouri, which has just one remaining abortion clinic because laws targeting the procedure made it more challenging for providers to stay open, women have lost access to medication abortions.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

NBCNews /  🏆 10. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

FDA OKs Automatic Use of Cheaper Generic InsulinFDA OKs Automatic Use of Cheaper Generic InsulinThe FDA has approved the first interchangeable insulin, allowing pharmacists to substitute brand name insulin with a more affordable version called Semglee.
Leer más »

FDA Says It's Working Quickly To Fully Approve Vaccines: ReportFDA Says It's Working Quickly To Fully Approve Vaccines: ReportThe agency previously said it will finish reviewing Pfizer's application by January, but full approval could also come before then.
Leer más »

FDA allowing troubled Covid vaccine factory that made J&J doses to restartFDA allowing troubled Covid vaccine factory that made J&J doses to restartThe FDA is allowing the problem-plagued factory of contract manufacturer Emergent BioSolutions to resume production of the Covid-19 vaccine, the company says.
Leer más »

Opinion | Why Is the FDA Attacking a Safe, Effective Drug?Opinion | Why Is the FDA Attacking a Safe, Effective Drug?From WSJopinion: Ivermectin is a safe and effective antiparasitic. Moreover, the drug can help treat Covid. So why is the FDA attacking a drug it previously approved? ask David R. Henderson and Charles L. Hooper
Leer más »

FDA okays Regeneron COVID-19 antibody as preventive in high-risk settingsFDA okays Regeneron COVID-19 antibody as preventive in high-risk settingsThe company said the authorization enables the therapy to be used in people exposed to an infected individual, orwho are at high risk of exposure to an infected individual in settings such as nursing homes or prisons. The combo therapy, REGEN-COV, was authorized in November for emergency use to treat people with mild-to-moderate COVID-19 in the United States.
Leer más »



Render Time: 2025-04-13 20:23:04